
Adaptive Biotechnologies Gehälter & Vergütung
Tech
Adaptive Biotechnologies develops an immune medicine platform for diagnosing and treating diseases, including cancer, autoimmune conditions, and infectious diseases. Its products include immunoSEQ, T-Detect COVID, clonoSEQ, and immunoSEQ T-MAP COVID. The company collaborates with Genentech and Microsoft to develop therapies and diagnostic tests. Adaptive Biotechnologies was founded in 2009 and is headquartered in Seattle, Washington.
Hauptsitz:Seattle, United States
Gegründet:2009
Mitarbeiter:201-1,000
Typ:public
Geschätzter Umsatz:$100M-$250M
6
Gehaltsangaben
$118K
Ø Gesamtvergütung
$130K
Median Gesamtvergütung
USD
Währung
Statistiken in USD (umgerechnet). Wähle ein Land für genaue lokale Zahlen.
Hauptsitz